Polymorphism of the FcγRIIIa gene and post-treatment apical periodontitis

J Endod. 2011 Oct;37(10):1345-8. doi: 10.1016/j.joen.2011.06.025. Epub 2011 Jul 30.

Abstract

Introduction: Polymorphisms of genes encoding leukocyte surface receptors for the constant region of immunoglobulin G (FcγR) might influence the host response to infection and consequently affect the outcome of the endodontic treatment. This study investigated the association of FcγRIIIa gene (FcγRIIIA) polymorphism with post-treatment apical periodontitis in Brazilian subjects.

Methods: The study population consisted of 26 patients with post-treatment apical periodontitis and 43 subjects with root canal-treated teeth exhibiting healthy/healing periradicular tissues (controls). All teeth had apical periodontitis lesions at the time of treatment, which was completed at least 1 year previously. Saliva was collected from the participants; DNA was extracted and used for FcγRIIIA genotyping.

Results: No significant associations were found between any specific genotype of FcγRIIIA (P = .63) or allele (P = .76) and post-treatment apical periodontitis. Overall, the most prevalent allele in the study population was FcγRIIIA-F158 (68.8%). The genotype V/F was the most common among the population, occurring in 50.7% of the subjects.

Conclusions: Data from the present study suggest that polymorphism in the FcγRIIIa does not influence the patient's response to endodontic treatment of teeth with apical periodontitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Brazil
  • Case-Control Studies
  • Chi-Square Distribution
  • Chronic Disease
  • Dental Restoration Failure*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Multiplex Polymerase Chain Reaction
  • Periapical Periodontitis / genetics*
  • Periapical Periodontitis / immunology*
  • Periapical Periodontitis / therapy
  • Polymorphism, Genetic
  • Receptors, IgG / genetics*
  • Root Canal Therapy
  • Saliva / chemistry
  • Treatment Failure*

Substances

  • FCGR3A protein, human
  • Receptors, IgG